How to Encourage People to Become Organ Donors: An Incentive System with Heart Knowledge@WhartonWhile the decision to register as an organ donor is a difficult one, no one can dispute the tremendous need for such donors. Approximately 110000…
Takeda to withdraw sNDA for lymphoma drug – Pharmaceutical Business Review
Takeda to withdraw sNDA for lymphoma drugPharmaceutical Business ReviewTakeda Pharmaceutical and its subsidiary the Takeda Oncology company – Millennium have made decision to withdraw the supplemental new drug application (sNDA) for the use of Velcade …
Laparoscopic versus open radical nephrectomy in T2 renal cell carcinoma: Long … – UroToday
Laparoscopic versus open radical nephrectomy in T2 renal cell carcinoma: Long …UroTodayLaparoscopic radical nephrectomy (LRN) has become the standard technique for radical nephrectomies for T1 renal tumors (7 cm or less). We extended our experience w…
CAMPERDOWN: Lab mice help with liver research breakthrough – Inner West Courier
Inner West CourierCAMPERDOWN: Lab mice help with liver research breakthroughInner West CourierThey hope the discovery will lead to new ways of treating organ transplant rejection, hepatitis C and other chronic liver diseases, Dr Bertolino, the head of …
Kidney Transplantation May Be Aided By Stem Cell Therapy – ThirdAge
ThirdAgeKidney Transplantation May Be Aided By Stem Cell TherapyThirdAgeA kidney transplantation followed by a new stem cell therapy may allow some patients to forego medications that prevent their body from attacking the new organ. As reported by Heal…
Takeda Pulls FDA Application for Expanded Use of Cancer Drug Velcade – Genetic Engineering News
Takeda Pulls FDA Application for Expanded Use of Cancer Drug VelcadeGenetic Engineering NewsMillennium: The Takeda Oncology Company has decided to withdraw its sNDA for Velcade in combination with rituximab for the treatment of relapsed follicular lymp…
iBio announces production of biosimilar rituximab drug, shares rally – Proactive Investors UK
iBio announces production of biosimilar rituximab drug, shares rallyProactive Investors UKiBio (AMEX:IBIO) shares rallied around 10% Wednesday after the company announced that its proprietary iBioLaunch technology has been used to produce a functional,…
Jonah Lomu Approved of Kidney Transplantation – TopNews New Zealand
TopNews New ZealandJonah Lomu Approved of Kidney TransplantationTopNews New ZealandJonah Lomu will be undergoing another Kidney transplantation surgery as his earlier transplantation has failed to work. The rugby player had undergone the transplantatio…
Robotic versus laparoscopic partial nephrectomy for bilateral synchronous … – UroToday
Robotic versus laparoscopic partial nephrectomy for bilateral synchronous …UroTodayThe median warm ischemia time was shorter in the RPN group than in the LPN group (19 vs 37 minutes, respectively; P = .059). The median tumor size was 2.85 and 2.7 cm …
iBio announces production of biosimilar rituximab drug, shares rally – Proactive Investors USA & Canada
Proactive Investors USA & CanadaiBio announces production of biosimilar rituximab drug, shares rallyProactive Investors USA & CanadaiBio (AMEX:IBIO) shares rallied around 10% Wednesday after the company announced that its proprietary iBioLaunch technol…